Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences

SAN DIEGO,Calif.,and SUZHOU and SHANGHAI,China,Aug. 29,2022 -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"),a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer,today announced that the management team will participate in and attend one-on-one meetings at four investor conferences in September 2022 as follows:

Wells Fargo Healthcare Conference 2022 (September 7 – 9,2022)

Fireside Chat: September 7 at 9:45 a.m. ET

One-on-one meetings: Wednesday,September 7,2022

Location: Boston,MA

Citi's 17th Annual BioPharma Conference (September 6 – 8,2022)

Panel Presentation: September 8 at 11:20 a.m. ET

One-on-one meetings: Thursday,September 8,MA

H.C. Wainwright 24th Annual Global Investment Conference (September 12 – 16,2022)

Presentation: September 12 at 3:30 p.m. ET

One-on-one meetings: Monday,September 12 & Friday,September 16,2022

Location: New York,NY and Virtual

Cantor Call and Genetic Medicines Conference (September 15,2022)

Panel Presentation: September 15 at 10:40 a.m. ET

One-on-one meetings: September 15,NY

Webcast of the presentations will be available on the News and Eventssection of Gracell's investor website. A replay of the webcast will be available for 30 days following the event.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART™technology module,Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies,including lengthy manufacturing time,suboptimal cell quality,high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell,please visit www.gracellbio.com and follow @GracellBio on LinkedIn.

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-four-upcoming-investor-conferences-301613526.html